NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0050 (-7.94%)
Oct 8, 2026, 2:09 PM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 22.6 million as of October 9, 2026. It is the 38,767th most valuable company in the world and the 1,054th biggest in Australia. Its market cap has decreased by 56.15% in one year.
Market Cap
22.60M
Enterprise Value
18.06M
Revenue
402.66K
Global Rank
Country Rank
#1,054 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 22.60M, an increase of 36.53%. That is a compound annual growth rate of 3.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 22.60M | -38.21% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 26.03M |
| Neurotech International | 22.62M |
| Radiopharm Theranostics | 21.69M |
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Noxopharm | 19.05M |
| Algorae Pharmaceuticals | 18.25M |
| Ceryvyn Therapeutics | 17.78M |